2 secret stocks expected to deliver brilliant profits growth

Royston Wild runs the rule over two shares predicted to deliver stonking profits growth now and next year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors in Lombard Risk Management (LSE: LRM) took fright and headed for the exits in Wednesday trade after the release of less-than-reassuring trading numbers.

The business, which provides collateral management and regulatory reporting solutions, announced that revenues ducked 16.4% during the six months to September, to £12.7m, a result it put down to “a temporary fall in services revenues and some delays in contract signings.”

As a result, pre-tax losses at Lombard Risk ballooned to £5.9m, from £100,000 a year earlier.

Chief executive Alastair Brown called the results “unsurprisingly pretty sober.”

He said: “A number of opportunities we had hoped to secure in the period remain in the pipeline as market distractions such as MiFID II caused companies to delay on committing to new projects.

This leaves us much to do in the second half, and converting our strong visible pipeline will be crucial to us meeting market forecasts,” he added.

A risk too far?

The City’s army of analysts had been expecting Lombard Risk to continue on its path of steady bottom-line improvement, flipping from losses of 0.18p per share in the year to March 2017, to earnings of 0.5p in the present period.

And earnings were predicted to continue tearing skywards beyond this year with the number crunchers touting a 152% earnings improvement — to 1.2p — in fiscal 2019.

Thanks to today’s whopping 31% share price slide, these current projections result in a forward P/E ratio of 14.7 times, below the widely-accepted benchmark of 15 times that signals decent value for money.

And some share pickers could argue that the scale of transformation over at Lombard Risk makes it worthy of consideration at these prices — indeed, Brown commented today: “during the period strong foundations have been put in place, with an improved salesforce, a new development centre in Birmingham, and a renewed effort to target new business as well as extant cross-selling opportunities.”

However, potential buyers should be on guard for meaty downgrades to earnings forecasts given the challenging trading conditions Lombard Risk is toiling in. I reckon risk-averse investors may want to sit on the sidelines for now.

Powering on

Flowtech Fluidpower (LSE: FLO) is another stock expected to deliver perky profits growth in the near-term and beyond, and I am much more happy to endorse its earnings outlook than Lombard Risk’s.

With demand for its hi-tech products continuing to swell — these shot 34% higher during January-September to £54.5m, Flowtech advised last week, or by 12.4% on an organic basis — it comes as no surprise that the company’s share price is following suit. It has just topped out at 179p per share, taking total gains since the turn of 2017 to 43%.

City experts anticipate much, much more to come, and are predicting a 35% earnings rise in 2017 to be followed with a 17% advance next year. And current estimates make Flowtech stunning value, too, with the firm rocking up on a prospective P/E multiple of 13 times, and a sub-1 PEG readout of 0.4.

I reckon those seeking great growth shares on a budget could do a lot worse than pile into the AIM star.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned.  The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »